CASI Pharmaceuticals Inc Sustainability Reports

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing innovative therapeutics and pharmaceutical products. The company primarily targets hematology-oncology applications and other areas of significant unmet medical need within the Greater China and global markets.

Sector: Manufacturing

Country: China

Exchange: Nasdaq

LEI: 549300RYDG4U21PJZ263

FIGI: BBG01DSTT3Z0

4 reports from 2017 to 2022

• CASI Pharmaceuticals Inc 2022 Form 20-F
• CASI Pharmaceuticals Inc 2021 Form 10-K
• CASI Pharmaceuticals Inc 2020 Form 10-K
• CASI Pharmaceuticals Inc 2017 Form 10-K